Andrographis paniculata (Burm.f.) Wall. Ex. Nees (A. Paniculata), i.e. Kalmegha is a medicinal plant traditionally used for various diseases such as fever, diarrhea, worm infestation, hepatic and skin diseases. Modern studies have also explicitly revealed that A. Paniculata has a wide range of pharmacological effects such as anti-inflammatory, anti-hyperglycemic, anti-diarrhoeal, anti-viral, anti-malarial, hepato-protective, anti-cancer, anti-human immunodeficiency virus (HIV), and also work as an immune stimulator. On the other hand, Gout (Vatarakta) is one common metabolic disorder which affects over 1% of the world's adult population. Objective: To assess the clinical efficacy of A. Paniculata in Gouty Arthritis. Study Design: A clinical research, prospective in style, wherein a hypothesis, based on the previous studies on the various effects of A. Paniculata, was made; to assess its efficacy in treating Gout. Methodology: Randomly selected patients (n = 31) were administered powder of A. Paniculata, 2 gms thrice daily with water, for 45 days with a follow-up in every 15 days for one month. Assessment of the treatment was based on before treatment (BT) and after treatment (AT) effects of A. Paniculata on the parameters namely; subjective, i.e. the symptoms of Gout and objective, i.e. the levels of Serum Uric Acid.
INTRODUCTION
With an increase in the erratic ways of dietary and life-style habits, we are witnessing an ever growing menace of several metabolic disorders. Gouty arthritis is one of them affecting over 1% of the world's adult population. 1 Modern aspect defines gout as a hereditary metabolic disease that is a form of acute arthritis and is marked by inflammation of the joints with the etiology of excessive uric acid in the blood (hyperuricemia) and deposits of urates of sodium in and around joints. Several different metabolic abnormalities may also cause hyperuricemia. 2 Gout is a disease of antiquity. Considering the symptoms and pathogenesis, Gout can be co-related with Vatarakta in Ayurvedic sciences. Some common symptoms of Vatarakta include; Kandu (Itching), Daha (Burning sensation), Ruja (Pain), Sira-ayama (Dilatation of the vessels), Toda (Pricking pain), Sphurana (Trembling or throbbing sensation), Sira-akunchana (Contraction), Shyav-twak (Cyanosis of skin), Rakta-twak (Reddish coloration of skin), Bheda (Splitting type of pain), Gourava (Heaviness), Suptata (Numbness), etc. 3 Modern Drugs used to treat acute attacks and prevent future attacks of Gout includes: Non-steroidal antiinflammatory drugs (NSAIDs), Colchicine and Corticosteroids, etc. Owing to the rise in awareness about the disease, its treatments and undesirable possible adverse effects of modern drugs, more and more people are opting for a safe and cost effective treatment options. In the past few years, there is growing an interest in Ayurveda, especially in the herbal sector, worldwide. 16 .
MATERIAL AND METHODS
A clinical study, made to observe the effect of Kalmegha (A. paniculata) in Vatarakta (Gout), was approved by the Research Development Committee (RDC) of Uttarakhand Ayurved University, Harrawala, Dehradun on July 28th, 2016.
1) Source of the drug:
The plant material, A. Paniculata, whole plant, used in the clinical study was procured from a reliable source of Dehradun market. Its authentication was done in the PG Department, DravyaGuna, UAC, Dehradun.
2) Identity, Purity and Strength:
At the same time, the whole plant of A.Paniculata was collected from the Non Wood Forest Products (NWFP) Division, Forest Research Institute (FRI), Dehradun and a herbarium specimen was made and deposited at the Systematic Botany Branch (SBB), FRI, Dehradun. The plant was authenticated and an Herb Registration Number -172435, dated November 17th, 2017 was assigned to it. This plant sample was set as standard.
Thin layer chromatography (TLC) technique was used to ascertain the identity and quality of the commercially available plant material through comparison of its TLC profile with that of the authenticated plant material used as standard. Results of the comparative TLC revealed that both the samples were qualitatively alike.
3) Preparation of drug for the clinical trial:
A total of 15 kgs of commercially available plant material of A.Paniculata was purchased and after cleaning, washing and shade drying, it was milled and a fine powder of 35 mesh size from a normal sieve was prepared.
4) Dosage and Duration of treatment: Dosage of 2 gms of
A.Paniculata powder thrice daily to be taken with water was prescribed. Patients of Gout associated with any severe arthritis condition like acute rheumatoid arthritis, crooked fingers (anguli-vakrata), mental confusion (moha) and tumor like hard swelling (arbud) will be excluded from the study.
5) Number of patients:

9) Assessment Criteria:
The assessment criteria of the clinical studies were both subjective and objective. a) Subjective (symptoms based): The outcome in the above table indicates that out of 11 symptoms assessed, in 7 symptoms namely, edema (shvyathu), stiffness (stabdhata), inflammation (shotha), heaviness (guruta), piercing pain (toda), fatigue (shram), and indigestion (ajirna), p value obtained was less than < 0.01 which is considered to be highly significant at 5% level of significance. In 3 symptoms namely, itching (kandu), numbness (suptata) and thirst (trishna), p value was found to be less than < 0.05 which is considered to be significant at 5% level of significance. It was only the symptom pallor (shwetata) which showed the p value > 0.05, which means that A.Paniculata shows no effect on pallor (shwetata) symptom of Vatarakta (Gout). b) Objective: Z Test was used to see the significant effect, if any, of A. Paniculata on the levels of Serum Uric Acid based upon 31 observations under study. Above table shows that the average values of Serum Uric Acid for BT is 6.73 ± 0.110 (mean ± SEM) and the same is 6.07 ± 0.10 for the AT. The sample correlation coefficient between BT and AT is found to be 0.713 which is highly significant at 1% level of significance as p value is less than 0.01. In addition, mean difference of Uric Acid was 0.655 mg/dl. The lower and upper bounds of this difference were found to be 0.492 mg/dl and 0.818 mg/dl respectively.
It shows that there is a significant difference between BT and AT of A. paniculata on Serum Uric Acid.
DISCUSSION
In both subjective and objective parameters, as mentioned above, a significant difference was found between BT and AT of using A. Paniculata. It is interesting to note that except for one patient, the Serum Uric Acid levels of the remaining 30 patients showed good improvement. This fact again confirms the already established blood purifying properties of A. Paniculata. And hence piercing pain (toda), which was present in every patient, got highly significant results with 83.87% of patients reported to have marked improvement.
Couple of patients (age > 55 years) gave no response in any of the subjective and objective parameters. It could be because of their already sluggish metabolism, due to chronicity and age factor. However, many patients in this age bracket responded well with the recent symptoms of pain in smaller joints.
There were no adverse or undesirable side effects noted, in terms of clinical presentation or lab investigation, post studies. It is important to note that Pathya-Apathya plays an important role in curing the disease. The patients, who followed the prescribed diet and life-style guidelines diligently, responded well and took less time to recover.
There were some other notable benefits too. One patient in the study was suffering from pitting nails, reported to have complete relief in this condition, after 45 days of the treatment. Another patient of psoriasis reported regression in the symptoms of psoriasis as well.
CONCLUSION
The present study illustrates that the overall effect of A.paniculata, with its Rasa, Guna, Veerya, Vipaka and Karma, corrects the metabolism and purifies the blood, eventually helping in disintegrating the pathogenesis (samprapti-vighatan) of Vatarakta (Gout 
